Lentigen Technology, Inc. Selects Novatek Environmental Monitoring Management Software

Lentigen Technology, Inc. Selects Novatek Environmental Monitoring Management Software
GMP manufacturing facility for Lentigen Technology, Inc. has chosen Novatek’s Environmental Monitoring (EM) software w/ mobile add-on as part of their dedicated EM program at their Gaithersburg, MD, USA site. Novatek’s automated Environmental Monitoring software helps life science manufacturers evolve to a risk-based approach for their EM programs....

GMP manufacturing facility for Lentigen Technology, Inc. has chosen Novatek’s Environmental Monitoring (EM) software w/ mobile add-on as part of their dedicated EM program at their Gaithersburg, MD, USA site.

Novatek’s automated Environmental Monitoring software helps life science manufacturers evolve to a risk-based approach for their EM programs. The use of sampling data for the identification and mitigation of risk becomes a critical element in this process.

Novatek International is pleased to welcome Lentigen to our ever valued global Environmental Monitoring Software clients: Ximedica, EirGenix Inc., KBI Biopharma, WuXi AppTec , Biocon, Hospira, Endo Pharmaceuticals, Pfizer, Medtronic, Ranbaxy, Biovest International, Inc., Lantheus Medical Imaging, DSM and many more.

Come see a demo of Novatek’s Environmental Monitoring Management Solution at the 13th Annual PDA Global Conference on Pharmaceutical Microbiology Oct. 15-17, 2018 in Bethesda, MD.

About Lentigen Technologies, Inc.
Lentigen focuses on harnessing the power of lentiviral gene delivery and expression technology for a wide variety of applications in biotechnology and medicine. We are leading experts for design, construction and production of lentiviral vectors. Lentigen has the expertise to support you in successfully translating your gene therapeutic strategy into the clinic. GMP Manufacturing, Materials Management, Validation, Quality Control, Quality Assurance and a focused Project Management ensure high quality of your customized lentiviral product and conformity with regulatory requirements. Since 2014, Lentigen is a wholly owned subsidy of Miltenyi Biotec, a global provider of innovative solutions in biomedical research and cell and gene therapy.

Source: ntint.com